Formulary
Tenoxicam: Indications, Dosing, Side Effects and Interactions
Tenoxicam clinical drug profile including indications, dosing, side effects, cautions and interactions.
MedNext Academy | 3 min read
Tenoxicam: Indications, Dosing, Side Effects and Interactions
Tenoxicam clinical drug profile including indications, dosing, side effects, cautions and interactions.
Indications and dose
**Pain and inflammation in rheumatic disease**
- **Adult** (By Mouth): 20 mg once daily.
- **Adult** (By Intravenous Injection, Or By Intramuscular Injection): 20 mg once daily as initial treatment for 1-2 days if oral administration not possible.
**Pain and inflammation in acute musculoskeletal disorders**
- **Adult** (By Mouth): 20 mg once daily for 7 days; maximum duration of treatment 14 days (including treatment by intravenous or intramuscular injection).
- **Adult** (By Intravenous Injection, Or By Intramuscular Injection): 20 mg once daily as initial treatment for 1-2 days if oral administration not possible.
Cautions
Allergic disorders; cardiac impairment (NSAIDs may impair renal function); cerebrovascular disease; coagulation defects; connective-tissue disorders; dehydration (risk of renal impairment); elderly (risk of serious side-effects and fatalities); heart failure; history of gastro-intestinal disorders (e.g. ulcerative colitis, Crohn's disease); ischaemic heart disease; may mask symptoms of infection; peripheral arterial disease; risk factors for cardiovascular events; uncontrolled hypertension
Contraindications
Active gastro-intestinal bleeding; active gastro-intestinal ulceration; history of gastro-intestinal bleeding related to previous NSAID therapy; history of gastro-intestinal perforation related to previous NSAID therapy; history of recurrent gastro-intestinal haemorrhage (two or more distinct episodes); history of recurrent gastro-intestinal ulceration (two or more distinct episodes); severe heart failure
Side effects
General side-effects: Common or very common Constipation; Crohn's disease aggravated; diarrhoea; gastrointestinal discomfort; gastrointestinal disorders; haemorrhage; headache; nausea; vomiting Uncommon Fatigue; oedema; skin reactions Rare or very rare Asthma; bronchospasm; depression; dyspnoea; hyperglycaemia; nervousness; palpitations; pancreatitis; severe cutaneous adverse reactions (SCARs); sleep disorders; vertigo; weight changes Frequency not known Agranulocytosis; alopecia; anaemia; angioedema; aplastic anaemia; confusion; eosinophilia; fertility decreased female; haemolytic anaemia; hallucination; heart failure; hepatic disorders; hypersensitivity; hypertension; leucopenia; malaise; nail disorder; nephritis tubulointerstitial; nephropathy; paraesthesia; photosensitivity reaction; platelet aggregation inhibition; purpura non-thrombocytopenic; renal failure (more common in patients with pre-existing renal impairment); thrombocytopenia; tinnitus; vasculitis; vision disorders Specific side-effects: Common or very common With oral use Dizziness; dry mouth; oral disorders Rare or very rare With oral use Embolism and thrombosis; metabolic disorder Frequency not known With oral use Drowsiness; eye irritation; eye swelling With parenteral use Appetite decreased; increased risk of arterial thromboembolism; increased risk of ischaemic stroke; increased risk of myocardial infarction; meningitis aseptic (patients with connective-tissue disorders such as systemic lupus erythematosus may be especially susceptible); neutropenia; oral ulceration Side-effects, further information For information about cardiovascular and gastrointestinal side-effects, and a possible exacerbation of symptoms in asthma, see Non-steroidal anti-inflammatory drugs
Interactions
**Other interactions (1):**
- Tabulated list of Colestyramine drug-drug interactions: Drug Class Drug(s) Anti-arrhythmics Amiodarone Anti-convulsants Valproate Anti-infectives Vancomycin, tetracycline Antimetabolites...
Pregnancy
Important safety information For tenoxicam MHRA/CHM advice: NSAIDs: potential risks following prolonged use after 20 weeks of pregnancy (June 2023) See Non-steroidal anti-inflammatory drugs .
Breast feeding
Use with caution during breast-feeding. Present in milk in animal studies.
Hepatic impairment
Manufacturer advises caution in mild to moderate impairment; avoid in severe impairment.
Renal impairment
In general, for NSAIDs the MHRA advises to avoid where possible; if necessary, use with caution (risk of fluid retention and further renal impairment, including renal failure). For tenoxicam , avoid in severe impairment. M
Medicinal forms
Medicinal forms No licensed medicines listed.
Clinical governance
**Author:** MedNext Clinical Team. **Clinical reviewer:** Dr Shameer Deen, MBBS, MS, MRCS. **Sources:** BNF, Indian Pharmacopoeia, CIMS India. **Correction:** Report errors at support@mednext.academy.
Inside MedNext for this topic
- 411 MedNext-authored chapters
- 80,000+ MCQ bank
- 15 study modes
- Growing visual cheat sheets
Study modes
- Notes
- MCQ
- Audio
- Video
- Visual
- 3D Anatomy
- Trace
- Flashcards
- Mnemonics
- Image Bank
- Clinical
- Microscopy
- Audio QBank
- Cadaver
- Book Match
Continue reading
Subject HubPharmacology Hub
All pharmacology resources in one place.
Drug SchedulesIndian Drug Schedules
Schedule H, H1, X and G classifications.
FormularyBrowse all drugs
Search 1,850+ drug profiles.
Study Tenoxicam in the MedNext app
Challenge yourself with targeted pharmacology MCQs on this drug class. Every explanation links back to the chapter that teaches the concept.
Start drug challengeExplore the full formulary

